Author:
Ware Alisha D.,Borowitz Michael J.
Publisher
Springer International Publishing
Reference57 articles.
1. Swerdlow S, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. Revised 4th ed. Lyon: International Agency for Research on Cancer (IARC); 2017.
2. Gebauer N, Bernard V, Feller AC, Merz H. ID3 mutations are recurrent events in double-hit B-cell lymphomas. Anticancer Res. 2013;33(11):4771–8.
3. Gebauer N, Bernard V, Gebauer W, Thorns C, Feller AC, Merz H. TP53 mutations are frequent events in double-hit B-cell lymphomas with MYC and BCL2 but not MYC and BCL6 translocations. Leuk Lymphoma. 2015;56(1):179–85.
4. Gebauer N, Bernard V, Thorns C, Feller AC, Merz H. Oncogenic MYD88 mutations are rare events in double-hit B-cell lymphomas. Acta Haematol. 2015;133(1):113–5.
5. Huang W, Medeiros LJ, Lin P, Wang W, Tang G, Khoury J, et al. MYC/BCL2/BCL6 triple hit lymphoma: a study of 40 patients with a comparison to MYC/BCL2 and MYC/BCL6 double hit lymphomas. Mod Pathol. 2018;31(9):1470–8.